JAPANESE regenerative medical firm ReproCELL is to merge two of its companies, with the new group based in Glasgow.
Biopta and Reinnervate will merge to form ReproCELL Europe with the aim of strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services and products through the integration of Biopta’s human tissue services with Reinnervate’s stem cell and 3D cell culture expertise.
Biopta, which counts eight of the top 10 pharmaceutical companies among its clients and has worked on more than 500 potential new medicines, was spun out of Glasgow Caledonian University in 2002 by its co-founders, Dr David Bunton, and Professor Chris Hillier. Dr Bunton has been named chief executive of ReproCELL Europe. Reinnervate was spun out of Durham University.
The company aims to grow its 21-strong workforce by 25 per cent over the next three years and plans to move to larger premises in Glasgow within the next nine months.
Dr Bunton, said: “The merger of the two UK companies is a great opportunity to build on the solid platform Biopta has in outsourced drug discovery services and combine this with Reinnervate’s expertise in 3D cell culture and stem cell technology.”
He added that as the drug market moves towards a personalised medicine approach, the company will be able to increase its market share by expanding its range of human tissue drug discovery assays and accelerate product launches.
Why are you making commenting on HeraldScotland only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here